DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts

Company Performance - DaVita HealthCare (DVA) closed at $151.53, down 0.84% from the previous trading session, underperforming the S&P 500's gain of 0.55% [1] - The upcoming earnings report is expected to show an EPS of $2.21, reflecting an 18.18% increase year-over-year, with quarterly revenue anticipated at $3.25 billion, up 3.47% from the previous year [2] Analyst Forecasts - Recent revisions to analyst forecasts for DaVita HealthCare are crucial, as they indicate near-term business trends and analysts' outlook on the company's health and profitability [3] - The Zacks Rank system, which incorporates estimate changes, currently ranks DaVita HealthCare as 2 (Buy) [5] Valuation Metrics - DaVita HealthCare has a Forward P/E ratio of 13.6, which is lower than the industry average of 19.29, indicating a valuation discount [6] - The company also has a PEG ratio of 0.74, significantly below the industry average PEG ratio of 2.06, suggesting favorable growth expectations relative to its price [7] Industry Context - The Medical - Outpatient and Home Healthcare industry, which includes DaVita HealthCare, holds a Zacks Industry Rank of 163, placing it in the bottom 36% of over 250 industries [8]